R Edward Coleman

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
    David T Price
    Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA
    J Urol 168:273-80. 2002
  2. ncbi Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry
    Bruce E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, 1101 E Marshall St Room 7013, Richmond, VA 23298 0170, USA
    Mol Imaging Biol 13:161-5. 2011
  3. ncbi PET in lung cancer staging
    R E Coleman
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Q J Nucl Med 45:231-4. 2001
  4. ncbi Is quantitation necessary for oncological PET studies? For
    R Edward Coleman
    Duke University Medical Center, Durham, NC 27710, USA
    Eur J Nucl Med Mol Imaging 29:133-5. 2002
  5. ncbi Positron emission tomography diagnosis of Alzheimer's disease
    R Edward Coleman
    Department of Radiology, Duke University Medical Center, Box 3949, Durham, NC 27710, USA
    Neuroimaging Clin N Am 15:837-46, x. 2005
  6. ncbi Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid
    R Edward Coleman
    Division of Nuclear Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Biother Radiopharm 24:469-75. 2009
  7. ncbi PET and PET/CT reports: observations from the National Oncologic PET Registry
    R Edward Coleman
    Department of Radiology, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Nucl Med 51:158-63. 2010
  8. ncbi Value of FDG-PET scanning in management of lung cancer
    R Edward Coleman
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical School, Durham NC 27710, USA
    Lancet 359:1361-2. 2002
  9. ncbi FDG imaging
    R E Coleman
    Duke University Medical Center, Box 3949, Durham, North Carolina 27710, USA
    Nucl Med Biol 27:689-90. 2000
  10. ncbi Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
    Michael R Zalutsky
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Nucl Med 49:30-8. 2008

Detail Information

Publications106 found, 100 shown here

  1. ncbi Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
    David T Price
    Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA
    J Urol 168:273-80. 2002
    ..Overall the data from this study suggest that FCH is preferable to FDG for PET of prostate carcinoma and support the need for future validation studies in a larger number of subjects...
  2. ncbi Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry
    Bruce E Hillner
    Department of Internal Medicine, Virginia Commonwealth University, 1101 E Marshall St Room 7013, Richmond, VA 23298 0170, USA
    Mol Imaging Biol 13:161-5. 2011
    ..This study seeks to assess the impact of dedicated brain positron emission tomography (PET) with 2-deoxy-2-[(18)F]fluoro-D-glucose on intended management of patients with primary and metastatic brain tumors...
  3. ncbi PET in lung cancer staging
    R E Coleman
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Q J Nucl Med 45:231-4. 2001
    ..PET is accurate in the staging of the mediastinum, adrenal glands, and the skeletal system. PET is not as accurate in the detection of brain metastases because of their small size and the normal cortical accumulation...
  4. ncbi Is quantitation necessary for oncological PET studies? For
    R Edward Coleman
    Duke University Medical Center, Durham, NC 27710, USA
    Eur J Nucl Med Mol Imaging 29:133-5. 2002
  5. ncbi Positron emission tomography diagnosis of Alzheimer's disease
    R Edward Coleman
    Department of Radiology, Duke University Medical Center, Box 3949, Durham, NC 27710, USA
    Neuroimaging Clin N Am 15:837-46, x. 2005
    ..Semiquantitative methods of image interpretation are available. Medicare covers FDG-PET imaging for the narrow indication of differentiation of possible AD from frontotemporal dementia...
  6. ncbi Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid
    R Edward Coleman
    Division of Nuclear Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Biother Radiopharm 24:469-75. 2009
    ..These findings support the further development of Ultratrace 131I-MIBG for the treatment of neuroendocrine tumors, such as metastatic Pheo and carcinoid...
  7. ncbi PET and PET/CT reports: observations from the National Oncologic PET Registry
    R Edward Coleman
    Department of Radiology, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Nucl Med 51:158-63. 2010
    ..Our objective was to identify core elements for inclusion in oncologic PET reports and to evaluate a sample of reports in the National Oncologic PET Registry database...
  8. ncbi Value of FDG-PET scanning in management of lung cancer
    R Edward Coleman
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical School, Durham NC 27710, USA
    Lancet 359:1361-2. 2002
  9. ncbi FDG imaging
    R E Coleman
    Duke University Medical Center, Box 3949, Durham, North Carolina 27710, USA
    Nucl Med Biol 27:689-90. 2000
    ..Semiquantitative indices such as the standardized uptake value may be used for research purposes to provide a quantitative parameter from the study...
  10. ncbi Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
    Michael R Zalutsky
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Nucl Med 49:30-8. 2008
    ..The main goal of this study was to investigate the feasibility and safety of this approach in patients with recurrent malignant brain tumors...
  11. ncbi A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
    David A Reardon
    Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA
    Neuro Oncol 10:182-9. 2008
    ..S. Food and Drug Administration has approved a trial randomizing newly diagnosed GBM patients to either our study regimen or standard XRT plus temozolomide...
  12. ncbi Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results
    David A Reardon
    Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, NC, 27710, USA
    J Clin Oncol 24:115-22. 2006
    ..To assess the efficacy and toxicity of intraresection cavity iodine-131-labeled murine antitenascin monoclonal antibody 81C6 (131I-m81C6) among recurrent malignant brain tumor patients...
  13. ncbi Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results
    David A Reardon
    Department of Surgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA
    J Nucl Med 47:912-8. 2006
    ....
  14. ncbi Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
    John H Sampson
    Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA
    Neuro Oncol 9:343-53. 2007
    ..6% of catheters. Routine use of this algorithm, and its further developments, should improve prospective selection of catheter trajectories, and thereby improve the efficacy of drugs delivered by this promising technique...
  15. ncbi Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
    R Edward Coleman
    Duke University Medical Center, Durham, North Carolina, USA
    J Am Coll Radiol 2:568-84. 2005
    ....
  16. ncbi Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study
    Gamal Akabani
    Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA
    J Nucl Med 46:1042-51. 2005
    ..Further clinical studies are warranted to determine the effectiveness of (131)I-mu81C6 mAb based on a target dose of 44 Gy rather than a fixed administered activity...
  17. ncbi Lexical and sublexical components of age-related changes in neural activation during visual word identification
    Wythe L Whiting
    Duke University Medical Center, Durham, NC 27710, USA
    J Cogn Neurosci 15:475-87. 2003
    ..We conclude that aging affects the neural mechanisms supporting word identification performance although behavioral measures of this ability are generally constant as a function of age...
  18. ncbi Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization
    G Chad Hughes
    Division of Cardiovascular Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Card Surg 19:21-7. 2004
    ..The purpose of the present study was to evaluate regional myocardial sympathetic innervation both early (3 days) and late (6 months) after TMR...
  19. ncbi Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
    John H Sampson
    Division of Neurosurgery, Department of Surgery, Box 3050, Room 220 Sands Building, Duke University Medical Center, Durham, NC 27710, USA
    Neuro Oncol 10:320-9. 2008
    ..However, the potential efficacy of drugs delivered by this technique may be severely constrained by ineffective infusion in many patients...
  20. ncbi Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma
    Jenny K Hoang
    Department of Radiology, Duke University Medical Center, Erwin Rd, Durham, NC 27710, USA
    J Clin Oncol 26:1459-64. 2008
    ....
  21. ncbi Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF
    G Chad Hughes
    Departments of Surgery and Medicine, Divisions of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC, USA
    Ann Thorac Surg 77:812-8. 2004
    ..This study expands on prior work by comparing the long-term proangiogenic effects of direct intramyocardial (IM) injection of bFGF, as well as IM and intravenous (IV) VEGF in a porcine model of chronic hibernating myocardium...
  22. ncbi Left ventricular functional assessment in mice: feasibility of high spatial and temporal resolution ECG-gated blood pool SPECT
    Bennett B Chin
    Department of Radiology, Duke University School of Medicine, Durham, NC 27710, USA
    Radiology 245:440-8. 2007
    ..To prospectively determine feasibility of evaluating murine left ventricular (LV) function with electrocardiographically (ECG)-gated blood pool single photon emission computed tomography (SPECT)...
  23. ncbi Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies
    Yuka Yamamoto
    Department of Radiology, Nuclear Medicine Division, Duke University Medical Center, Durham, NC, USA
    Radiology 244:263-72. 2007
    ....
  24. ncbi Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease
    Simon L Bacon
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA
    Int J Psychophysiol 61:143-8. 2006
    ..Reduced plasma volume may be one mechanism by which mental stress may increase the risk for acute coronary events...
  25. ncbi Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h
    Bennett B Chin
    Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, NC, USA
    Mol Imaging Biol 11:118-22. 2009
    ..Increasing FDG uptake in normal organs, however, may mitigate the beneficial effects of blood pool clearance. The purpose of this study is to determine the normal tissue and blood pool FDG uptake at 1 and 3 h after injection...
  26. ncbi Clinical applications of PET in oncology
    Eric M Rohren
    Department of Radiology, Duke University Medical Center, Rm 1410, Duke North, Erwin Rd, Durham, NC 27710, USA
    Radiology 231:305-32. 2004
    ..Other applications are being used clinically but have not been as carefully evaluated in the literature, and these applications may not be covered by third-party payers. The developing applications of PET are included in this review...
  27. ncbi Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence
    Joerg Gauger
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Thorac Oncol 2:499-505. 2007
    ..The purpose of this study was to determine the sites and time to recurrence in patients with clinical stage I NSCLC whose initial staging evaluation included conventional imaging and fluorodeoxyglucose-PET...
  28. ncbi Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
    Jennifer L Shaffer
    Department of Radiology, Department of Psychiatry and Medicine, and Duke Institute for Brain Sciences, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710 The Mind Research Network, Albuquerque, NM
    Radiology 266:583-91. 2013
    ..FDG PET appears to add the greatest prognostic information. © RSNA, 2012 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120010/-/DC1...
  29. ncbi Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin
    John H Sampson
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    AJR Am J Roentgenol 188:703-9. 2007
    ..Our purpose was to test the hypothesis that hyperintense signal changes on T2-weighted images produced by such infusions can be used to track drug distribution...
  30. ncbi 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging
    Yuka Yamamoto
    Department of Radiology, Nuclear Medicine Division, Duke University Medical Center, Durham, NC, USA
    Mol Imaging Biol 8:340-7. 2006
    ....
  31. ncbi Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease
    Michael A Babyak
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 105:25-8. 2010
    ..7, (95% confidence interval 1.1 to 2.6, p = 0.011). In conclusion, reductions in the LVEF during mental stress are prospectively associated with adverse clinical outcomes...
  32. ncbi Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables
    S T Mast
    Division of Cardiology, Department of Internal Medicine, Duke University Medical Center and Health Systems, Durham, North Carolina 27710, USA
    J Nucl Med 42:871-7. 2001
    ..In patients who cannot exercise and are undergoing noninvasive evaluation with pharmacologic stress testing and myocardial perfusion imaging, ejection fraction should be measured simultaneously for risk assessment optimization...
  33. ncbi Adult age differences in visual word identification: functional neuroanatomy by positron emission tomography
    David J Madden
    Duke University Medical Center, Durham, NC 27710, USA
    Brain Cogn 49:297-321. 2002
    ....
  34. ncbi Recommendations on the use of 18F-FDG PET in oncology
    James W Fletcher
    Department of Radiology, Indiana Purdue University, Indiana University School of Medicine, Indianapolis, Indiana 46202 5253, USA
    J Nucl Med 49:480-508. 2008
    ..In addition, (18)F-FDG PET should be used to detect recurrence of breast, colorectal, head and neck, or thyroid cancer and of lymphoma...
  35. ncbi A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules
    James W Fletcher
    Department of Radiology, Indiana University School of Medicine, University Hospital, Indianapolis, Indiana 46202 5253, USA
    J Nucl Med 49:179-85. 2008
    ..Our objective was to compare CT and PET accuracy in veterans with SPN...
  36. ncbi PET and brain tumor image fusion
    Terence Z Wong
    Department of Radiology, Nuclear Medicine Division, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer J 10:234-42. 2004
    ....
  37. ncbi A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer
    Gonzalo V Gonzalez-Stawinski
    Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Thorac Cardiovasc Surg 126:1900-5. 2003
    ..Cervical mediastinoscopy with lymph node biopsy remains the criterion standard for mediastinal staging...
  38. ncbi Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease
    Salvador Borges-Neto
    Department of Medicine Cardiology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Cardiol 95:182-8. 2005
    ..This information may be useful for stratifying patients into multiple risk categories for future cardiovascular events and potentially guiding therapy...
  39. ncbi Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma
    Shawn D Safford
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Surgery 134:956-62; discussion 962-3. 2003
    ..An initial dose of 500 mCi may be optimal. The benefit of (131)I-MIBG treatment for metastatic pheochromocytoma must also be weighed against its side effects...
  40. ncbi Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients
    Shawn D Safford
    Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
    Cancer 101:1987-93. 2004
    ..Improved survival was predicted best by symptomatic response to 131I-MIBG treatment, but not by hormone or radiographic response...
  41. ncbi Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience
    Eric L Rosen
    Department of Radiology, Duke University Medical Center, Room 24244B, Hospital South, Durham, NC 27710, USA
    Radiology 234:527-34. 2005
    ..To prospectively assess a dedicated, large field of view positron emission tomography (PET) mammographic device for imaging primary breast carcinoma...
  42. ncbi Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group
    Richard L Wahl
    Division of Nuclear Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Clin Oncol 22:277-85. 2004
    ..To determine the accuracy of positron emission tomography with fluorine-18-labeled 2-fluoro-2-deoxy-d-glucose (FDG-PET) in detecting axillary nodal metastases in women with primary breast cancer...
  43. ncbi Practical approach to diagnostic CT combined with PET
    Terence Z Wong
    Department of Radiology, Duke University Medical Center, Box 3949 Duke University Medical Center, Durham, NC 27710, USA
    AJR Am J Roentgenol 188:622-9. 2007
    ..Standardization of imaging protocols will become increasingly important as multiple-institution trials are developed for evaluation of present and future applications of PET/CT...
  44. ncbi Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
    David A Rizzieri
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Blood 104:642-8. 2004
    ..These data demonstrate this radiopharmaceutical to be an encouraging agent for the treatment of lymphoma particularly if methods to protect the normal viscera are developed...
  45. ncbi Regional brain activity correlates of nicotine dependence
    Jed E Rose
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27705, USA
    Neuropsychopharmacology 32:2441-52. 2007
    ..The results also highlight the likely role of thalamic gating processes as well as striatal reward and corticolimbic regulatory pathways in the maintenance of cigarette addiction...
  46. ncbi Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy
    Eric M Rohren
    Department of Radiology, Duke University Medical Center, Durham, NC, USA
    Radiology 226:181-7. 2003
    ....
  47. ncbi Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma
    Sridharan Gururangan
    The Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC 27710, USA
    J Neurooncol 77:207-12. 2006
    ..We performed a retrospective study of patients with diffuse pontine glioma (DPG) who suffered neuraxis metastasis (NM) and characterized the incidence, clinical features, radiologic findings, and patterns of disease dissemination...
  48. ncbi Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers
    T R DeGrado
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Nucl Med 42:1805-14. 2001
    ..Preliminary PET studies on patients with prostate cancer and with breast cancer and brain tumor support further studies to evaluate the usefulness of FCH as an oncologic probe...
  49. ncbi Combination of converging collimators for high-sensitivity brain SPECT
    Ruben Ter-Antonyan
    Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA
    J Nucl Med 50:1548-56. 2009
    ..The reason for combining collimators is to ensure both high sensitivity and sufficient sampling without trading off spatial resolution...
  50. ncbi Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi
    Salvador Borges-Neto
    Department of Medicine, Duke Clinical Research Institute and Drexel School of Medicine, Duke University Medical Center, PO Box 3949, Durham, NC 27710, USA
    Radiology 232:58-65. 2004
    ....
  51. ncbi Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements
    Tira Bunyaviroch
    Department of Radiology, Nuclear Medicine Section, Duke University Medical Center, Durham, NC 27710, USA
    Mol Imaging Biol 10:107-13. 2008
    ..Newer CT-based attenuation correction (CTAC) algorithms have been developed to reduce these errors...
  52. ncbi Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging
    Lawrence Liao
    Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    J Nucl Med 46:5-11. 2005
    ..7, and 16.7, respectively). CONCLUSION: The DTS, perfusion SPECT, and RNA-EF are each significant predictors of cardiovascular events in high-risk patients. The optimal risk stratification of patients for CAD may include all 3 modalities...
  53. ncbi Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study
    John H Sampson
    Duke University Medical Center, Durham, NC 27710, USA
    Neuro Oncol 7:90-6. 2005
    ..This report describes a dramatic and sustained clinical and radiographic response in a patient with a bifrontal glioblastoma multiforme treated with intratumoral infusion of a novel targeted toxin, TP-38...
  54. ncbi ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology
    Terence Z Wong
    Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Box 3949, Durham, NC 27710, USA
    AJR Am J Roentgenol 184:676-80. 2005
  55. ncbi Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT
    Sreekanth Vemulapalli
    Department of Medicine, Division of Cardiology, Duke University Medical Center, Box 3808 DUMC, Durham, NC 27710, USA
    Radiology 242:198-207. 2007
    ....
  56. ncbi Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury
    Pehr A Lind
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 54:340-7. 2002
    ..Additional studies are needed to better understand the dosimetric/functional determinants of radiation pneumonitis...
  57. ncbi Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial
    James A Blumenthal
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 293:1626-34. 2005
    ..Observational studies have shown that psychosocial factors are associated with increased risk for cardiovascular morbidity and mortality, but the effects of behavioral interventions on psychosocial and medical end points remain uncertain...
  58. ncbi Positron emission tomography imaging of brain tumors
    Terence Z Wong
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Box 3949, Durham, NC 27710, USA
    Neuroimaging Clin N Am 12:615-26. 2002
    ..These tracers may be useful in specific clinical situations, however, such as tumor localization for treatment planning or evaluation of low-grade tumors...
  59. ncbi Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study
    P Murali Doraiswamy
    Duke University Medical Center, Durham, NC, USA
    Neurology 79:1636-44. 2012
    ..We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline...
  60. ncbi Clinical oncologic positron emission tomography: an introduction
    Timothy G Turkington
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Box 3949, DUMC, Durham, NC 27710, USA
    Semin Roentgenol 37:102-9. 2002
    ..Third-party payers now recognize the importance of PET imaging in multiple malignancies. The number of PET scans performed annually will continue to increase as the indications increase and the instrumentation is more available...
  61. ncbi Mammotomography with pinhole incomplete circular orbit SPECT
    Martin P Tornai
    Section of Nuclear Medicine, Department of Radiology, Duke University Medical Center, DUMC 3949, Durham, NC 27710, USA
    J Nucl Med 44:583-93. 2003
    ..Enhanced 3-dimensional imaging performance with very-high-stopping-power apertures is thought to ultimately yield improved sensitivities for lesion detection and identification in breast disease...
  62. ncbi Neuroimaging and early diagnosis of Alzheimer disease: a look to the future
    Jeffrey R Petrella
    Department of Radiology, Duke University Medical Center, Duke Hospital North, Rm 1513, Erwin Rd, Durham, NC 27710, USA
    Radiology 226:315-36. 2003
    ..PET ligands are in late-stage development for demonstration of amyloid plaques, and human studies have already begun. Functional MR-based memory challenge tests are in development as well...
  63. ncbi Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
    R Edward Coleman
    Duke University Medical Center, Durham, North Carolina, USA
    J Nucl Med 46:1225-39. 2005
    ....
  64. ncbi Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols
    Robert A Pagnanelli
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA
    J Nucl Med Technol 30:175-8. 2002
    ..The gated (99m)Tc-TET/(18)F-FDG DISA protocol can be both a reliable and an efficient way to evaluate myocardial function, perfusion, and viability...
  65. ncbi Quantitative pulmonary single photon emission computed tomography for radiotherapy applications
    C Scarfone
    Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Med Phys 26:1579-88. 1999
    ..SPECT has the potential to provide accurate estimates of lung activity distributions that, together with improved image quality, may be useful for the study and prediction of therapeutic response...
  66. ncbi Pharmacokinetics and radiation dosimetry of 18F-fluorocholine
    Timothy R DeGrado
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Nucl Med 43:92-6. 2002
    ..18F-Fluorocholine (fluoromethyl-dimethyl-2-hydroxyethylammonium [FCH]) has been developed as an oncologic probe for PET. This study evaluates the kinetics and radiation dosimetry of 18F-FCH using murine and human biodistribution data...
  67. ncbi [18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma
    Sridharan Gururangan
    The Brain Tumor Center at Duke, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
    Neurosurgery 55:1280-8; discussion 1288-9. 2004
    ..We evaluated the [(18)F]fluorodeoxyglucose (FDG) accumulation during positron emission tomography (PET) in patients with medulloblastoma and examined the relationship of intensity of uptake with patient outcome after the initial scan...
  68. ncbi Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies
    Thomas A D'Amico
    Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 74:160-3; discussion 163. 2002
    ..Positron emission tomography (PET) has been demonstrated to improve staging in patients with thoracic malignancies. This study evaluates the ability of a new imaging technique to improve the spatial resolution and accuracy of PET...
  69. ncbi Incidental detection of pigmented villonodular synovitis on FDG PET
    Mehmet T Kitapci
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Nucl Med 28:668-9. 2003
    ....
  70. ncbi PET studies of the influences of nicotine on neural systems in cigarette smokers
    Jed E Rose
    Veterans Affairs Medical Center, Durham, NC, USA
    Am J Psychiatry 160:323-33. 2003
    ..The effects of acute nicotine administration and smoking on brain function were investigated in two studies, with the primary goal of identifying neural systems that mediate these effects...
  71. ncbi Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
    David A Reardon
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 20:1389-97. 2002
    ..To assess the efficacy and toxicity of intraresection cavity (131)I-labeled murine antitenascin monoclonal antibody 81C6 and determine its true response rate among patients with newly diagnosed malignant glioma...
  72. ncbi Aging and attentional guidance during visual search: functional neuroanatomy by positron emission tomography
    David J Madden
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA
    Psychol Aging 17:24-43. 2002
    ....
  73. ncbi A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium
    G Chad Hughes
    Department of Surgery, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina, USA
    J Am Coll Cardiol 39:1220-8. 2002
    ....
  74. ncbi Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions
    Joshua M Wilson
    Graduate Program in Medical Physics, Duke University, Durham, North Carolina, USA
    Nucl Med Commun 32:868-72. 2011
    ..Reducing the total scan time will limit the opportunity for motion, which can reduce imaging artefacts and improves image fusion, will improve a patient's experience, and will yield the biggest gains in time for the tallest patients...
  75. ncbi Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer
    Terence Z Wong
    Departments of Radiology and Radiation Oncology, Duke University Medical Center, Durham, NC, USA
    Mol Imaging Biol 6:55-62. 2004
    ..To assess the accuracy of positron emission tomography (PET) with 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) for evaluating local and distant disease in patients with cervical cancer...
  76. ncbi Depression and increased myocardial ischemic activity in patients with ischemic heart disease
    Wei Jiang
    Departments of Department ofPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Am Heart J 146:55-61. 2003
    ..The observed inverse association between higher level of depressive symptoms and ischemic activity needs to be further assessed in large samples...
  77. ncbi Aging and recognition memory: changes in regional cerebral blood flow associated with components of reaction time distributions
    D J Madden
    Box 2980, Duke University Medical Center, Durham, NC 27710 USA
    J Cogn Neurosci 11:511-20. 1999
    ..The data suggest that the attentional demands of this task are relatively greater for older adults and consequently lead to the recruitment of additional neural systems during task performance...
  78. ncbi Fractal texture analysis of perfusion lung scans
    G D Tourassi
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Comput Biomed Res 33:161-71. 2000
    ..The average fractal dimension (FD) of normal ROIs was statistically significantly higher than that of abnormal ROIs. Furthermore, the FDs of abnormal ROIs with PE were significantly lower than the FDs of ROIs with OPD present...
  79. ncbi Association of bone scintigraphic abnormalities with knee malalignment and pain
    V B Kraus
    Duke General Clinical Research Unit, Duke University Medical Center, Durham, NC 27710, USA
    Ann Rheum Dis 68:1673-9. 2009
    ..The information content of knee bone scintigraphy was evaluated, including pattern, localisation and intensity of retention relative to radiographic features of knee osteoarthritis, knee alignment and knee symptoms...
  80. ncbi Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
    G Akabani
    Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 46:947-58. 2000
    ....
  81. ncbi Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors
    M U Khan
    Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center, Durham, NC27710, USA
    Q J Nucl Med Mol Imaging 52:441-54. 2008
    ..In this article, we review the current state of the art in the diagnosis and treatment of carcinoid tumors as well as the role of MIBG in their diagnosis and management...
  82. ncbi Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction
    J E Rose
    Nicotine Research Program, Duke University and V A Medical Center, Durham, NC 27705, USA
    Drug Alcohol Depend 56:99-107. 1999
    ..These results have significant implications for theories of addiction to nicotine as well as other drugs such as cocaine that may be subject to binding by lung tissue...
  83. ncbi Emotional responsivity and transient myocardial ischemia
    R A Carels
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Consult Clin Psychol 67:605-10. 1999
    ..These results suggest that emotional responsivity may represent an individual difference characteristic that is associated with an increased likelihood of exhibiting myocardial ischemia in both the laboratory and the real-world setting...
  84. ncbi Adult age differences in the functional neuroanatomy of verbal recognition memory
    D J Madden
    Center for the Study of Aging and Human Development, and Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA
    Hum Brain Mapp 7:115-35. 1999
    ....
  85. ncbi Cerebellar activity and disturbed time sense after THC
    R J Mathew
    Department of Psychiatry and Radiology, Duke University Medical Center, Box 3972, Durham, NC 27710, USA
    Brain Res 797:183-9. 1998
    ..The relationship between decreased cerebellar flow and impaired time sense is of interest because the cerebellum has been linked to an internal timing system...
  86. ncbi Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results
    D D Bigner
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 16:2202-12. 1998
    ..To determine the maximum-tolerated dose (MTD) of iodine 131 (131I)-labeled 81C6 monoclonal antibody (mAb) in brain tumor patients with surgically created resection cavities (SCRCs) and to identify any objective responses to this treatment...
  87. ncbi Multifractal texture analysis of perfusion lung scans as a potential diagnostic tool for acute pulmonary embolism
    G D Tourassi
    Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA
    Comput Biol Med 31:15-25. 2001
    ..Linear and non-linear decision models were evaluated for the diagnostic task. A consensus neural network significantly outperformed all decision models including the physicians...
  88. ncbi Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies
    G C Ravizzini
    Dept of Radiology (Nuclear Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Nucl Med Commun 23:203-8. 2002
    ..These factors may be considered for efficiency improvement in nuclear cardiology laboratories using 99mTc perfusion tracers...
  89. ncbi Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects
    M T Munley
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Lung Cancer 23:105-14. 1999
    ..The utilization of accurate nuclear medicine image reconstruction techniques and TCT may improve the treatment planning process...
  90. ncbi Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol
    S Borges-Neto
    Departments of Radiology Nuclear Medicine, Duke University Medical Center and Health Systems, Duke North Rm 1410, Durham, NC 27710, USA
    Radiology 215:529-33. 2000
    ....
  91. ncbi Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
    G C Hughes
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Ann Thorac Surg 72:163-8. 2001
    ....
  92. ncbi Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
    I Cokgor
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 18:3862-72. 2000
    ....
  93. ncbi Positron emission tomography: brain tumors and lung cancer
    R J Hagge
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Radiol Clin North Am 39:871-81. 2001
    ..Truly, FDG-PET has earned its place as the new standard of care in imaging non-small cell lung cancer...
  94. ncbi Effects of specific activity on meta-[(131)I]iodobenzylguanidine kinetics in isolated rat heart
    T R DeGrado
    Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA
    Nucl Med Biol 25:59-64. 1998
    ..5 nmol/g. Extrapolation of these results to human studies indicates that isotope-exchange-labeled [123I]MIBG has a specific activity sufficiently high to avoid mass effects on its heart retention...
  95. ncbi Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer
    T R DeGrado
    Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Res 61:110-7. 2001
    ..It is concluded that FCH closely mimics choline uptake by normal tissues and prostate cancer neoplasms. FCH is potentially useful as a PET tracer for detection and localization of prostate cancer and monitoring effects of therapy...
  96. ncbi Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints
    L B Marks
    Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Int J Radiat Biol 76:469-75. 2000
    ..To assess the relationship between radiation (RT)-induced pulmonary symptoms and subclinical changes in pulmonary functions tests (PFT) and radiographs...
  97. ncbi Prediction of myocardial perfusion abnormalities by quantitative regional function using a radionuclide angiography database: a comparison with wall motion analysis
    S Borges-Neto
    Department of Radiology Nuclear Medicine, Duke University Medical Center and Health Systems, Durham, North Carolina 27710, USA
    Clin Nucl Med 25:110-4. 2000
    ..A new assessment of regional ejection fraction at rest and peak exercise by first-pass radionuclide angiography using a "normal" database file has been developed...
  98. ncbi Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
    M Fan
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 19:543-50. 2001
    ..To determine whether changes in whole-lung pulmonary function test (PFT) values are related to the sum of predicted radiation therapy (RT)-induced changes in regional lung perfusion...
  99. ncbi Relating radiation-induced regional lung injury to changes in pulmonary function tests
    M Fan
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 51:311-7. 2001
    ..Additional studies to clarify the relationship between regional and global lung injury are needed...
  100. ncbi (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis
    D J Fiorella
    Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA
    AJNR Am J Neuroradiol 22:1291-9. 2001
    ....
  101. ncbi Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats
    R E Albright
    Department of Medicine Neurology, Duke University Medical Center, Durham, North Carolina 27710
    Stroke 19:1404-10. 1988
    ....